Skip to Main Content

Paper Details

Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nat Commun
62
2019
CREBBP, Chromatin, EP300, H3K9me3, MYC, TSS, TSSs, cancer, cancers, chromatin, human, human papillomavirus, hypermethylated subtype, oropharyngeal carcinoma, promoter region, promoter-associated CpG islands, transcription start sites, transcriptional start site, tumor
CREB-Binding Protein, Cell Line, Tumor, Chromatin, DNA Methylation, Datasets as Topic, E1A-Associated p300 Protein, Gene Expression Regulation, Neoplastic, Gene Silencing, Histones, Humans, Mutation, Neoplasms, Proto-Oncogene Proteins c-myc, Signal Transduction, Transcription Initiation Site
Author NameAffiliation
Mizuo AndoMoores Cancer Center, University of California San Diego
Mizuo AndoGraduate School of Medicine, University of Tokyo
Yuki SaitoMoores Cancer Center, University of California San Diego
Yuki SaitoGraduate School of Medicine, University of Tokyo
Guorong XuCenter for Computational Biology and Bioinformatics, University of California San Diego
Nam Q BuiUniversity of California San Diego
Nam Q BuiStanford University School of Medicine
Kate Medetgul-ErnarMoores Cancer Center, University of California San Diego
Minya PuMoores Cancer Center, University of California San Diego
Kathleen M FischCenter for Computational Biology and Bioinformatics, University of California San Diego
Kathleen M FischCenter for Computational Biology and Bioinformatics, University of California San Diego
Shuling RenMoores Cancer Center, University of California San Diego
Akihiro SakaiMoores Cancer Center, University of California San Diego
Takahito FukusumiMoores Cancer Center, University of California San Diego
Chao LiuMoores Cancer Center, University of California San Diego
Sunny HaftMoores Cancer Center, University of California San Diego
John PangMoores Cancer Center, University of California San Diego
Adam MarkCenter for Computational Biology and Bioinformatics, University of California San Diego
Daria A GaykalovaJohns Hopkins University School of Medicine
Theresa GuoJohns Hopkins University School of Medicine
Theresa GuoJohns Hopkins University School of Medicine
Alexander V FavorovSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Alexander V FavorovVavilov Institute of General Genetics, Russian Academy of Sciences
Alexander V FavorovSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Alexander V FavorovVavilov Institute of General Genetics, Russian Academy of Sciences
Srinivasan YegnasubramanianSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Elana J FertigSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Patrick K HaUniversity of California San Francisco
Pablo TamayoMoores Cancer Center, University of California San Diego
Pablo TamayoMoores Cancer Center, University of California San Diego
Tatsuya YamasobaGraduate School of Medicine, University of Tokyo
Trey Ideker (CM4AI)University of California San Diego
Trey Ideker (CM4AI)University of California San Diego
Karen MesserMoores Cancer Center, University of California San Diego
Joseph A CalifanoMoores Cancer Center, University of California San Diego
Joseph A CalifanoUniversity of California San Diego
  • 1 - 36

Datasets